InvestorsHub Logo

doogdilinger

12/28/17 9:53 AM

#31975 RE: illmatix0711 #31974

PODRAS, Regabatin and their Oxy candidate will make or break this company next year.

They must show progress on 1 of the 3 soon along with increased SeroquelXR sales and at least 1 of Pristiq or Lamictal FDA approved in the 1st 6 months of 2018 in order to stave off another dilutive offering.

I think they will and then IPCI will finally be on track to becoming the company most still here thought/believed it could become glta